Latest News about MRK
Recent news which mentions MRK
From Benzinga
These Vanguard ETFs Show Where the Smart Money Is Moving Now
March 03, 2025
From Motley Fool
Decoding Merck & Co's Options Activity: What's the Big Picture?
February 27, 2025
Tickers
MRK
From Benzinga
NovoCure Q4 EPS Misses, Revenue Matches
February 27, 2025
From Motley Fool
From Motley Fool
Wall Street Thinks This Weight-Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk
February 24, 2025
From Motley Fool
From Benzinga
Trade War Redux: These ETFs Due For Bumpy Ride Thanks To Trump Tariffs On Auto, Pharma, Chip Imports
February 19, 2025
From Benzinga
Europe Approves Merck's Cancer Drug For Two Indications
February 18, 2025
From Benzinga
From Benzinga
From Benzinga
Beyond The Numbers: 13 Analysts Discuss Merck & Co Stock
February 18, 2025
Tickers
MRK
From Benzinga
Trump's Tax Cut Could Add $4.6 Trillion To Deficit, With $48 Billion Tax Relief For Top 100 Firms: Robert Reich
February 18, 2025
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 14, 2025
From Benzinga
Decoding Merck & Co's Options Activity: What's the Big Picture?
February 13, 2025
Tickers
MRK
From Benzinga
Robert F. Kennedy, Vaccine Skeptic, Confirmed As Trump's Secretary Of Health: Health Care Stocks To Watch
February 13, 2025
From Benzinga
3 Blue-Chip Dividend Stocks Trading at Multiyear Lows
February 13, 2025
From Motley Fool
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
February 13, 2025
From Motley Fool
Gilead Sciences Beats Q4 EPS Forecast
February 11, 2025
From Motley Fool
Recent Filing Shows That Rep. Josh Gottheimer Sold Over $54K Worth of Merck & Co Stock
February 11, 2025
From Benzinga
Better High-Yield Dividend Stock: Pfizer vs. Merck
February 10, 2025
From Motley Fool
Top 3 Health Care Stocks You'll Regret Missing This Month
February 06, 2025
From Benzinga
Analysts Defend Merck Amid Investor Concerns Over Weak Guidance
February 05, 2025
From Benzinga
US Stocks Rise Despite China's Trade Fears, Palantir Defies Gravity, Gold Rallies Further: What's Driving Markets Tuesday?
February 04, 2025
From Benzinga
Merck's Gardasil Vaccine Slowdown In China Bites Again, Stock Falls On Weak 2025 Outlook
February 04, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.